Clinical effectiveness of posaconazole versus fluconazole as antifungal prophylaxis in hematology–oncology patients: a retrospective cohort study-Reference-Cited by-同舟云学术

Clinical effectiveness of posaconazole versus fluconazole as antifungal prophylaxis in hematology–oncology patients: a retrospective cohort study

Published:2014-03-19 Issue:3 Volume:3 Page:667-673
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Kung Hsiang‐Chi¹²,Johnson Melissa D.³⁴,Drew Richard H.³⁴,Saha‐Chaudhuri Paramita²⁵,Perfect John R.³

Affiliation:

1. Division of Infectious Diseases Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan

2. Duke Clinical Research Institute Durham North Carolina

3. Division of Infectious Diseases Duke University Medical Center Durham North Carolina

4. Campbell University College of Pharmacy and Health Sciences Buies Creek North Carolina

5. Department of Biostatistics and Bioinformatics Duke University School of Medicine Durham North Carolina

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.225

Reference15 articles.

1. Fungal Infections in Leukemia Patients: How Do We Prevent and Treat Them?

2. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15‐year period (1989–2003);Chamilos G.;Haematologica,2006

3. Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study

4. Antifungal therapy for febrile neutropenia: issues in clinical trial design;Marr K. A.;Curr. Opin. Investig. Drugs,2004

5. Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preferred Therapy for Specific Fungal Pathogens;2024 Nelson’s Pediatric Antimicrobial Therapy;2024-02-12

2. Epidemiology of Mucormycosis in Greece; Results from a Nationwide Prospective Survey and Published Case Reports;Journal of Fungi;2023-03-29

3. Preferred Therapy for Specific Fungal Pathogens;2023 Nelson’s Pediatric Antimicrobial Therapy;2023-03-01

4. Real-life comparison of posaconazole versus fluconazole for primary antifungal prophylaxis during remission-induction chemotherapy for acute leukemia;Journal of the Association of Medical Microbiology and Infectious Disease Canada;2023-03-01

5. Real‐world effectiveness of antifungal prophylaxis with posaconazole as the primary agent in patients with haematological malignancies;Mycoses;2022-07-25